The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells.

This publication has 20 references indexed in Scilit:

• Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
  New England Journal of Medicine, 1991
• Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells.
  The Journal of cell biology, 1991
• Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
  New England Journal of Medicine, 1990
• Differential expression of genes encoding α, β and γ retinoic acid receptors and CRABP in the developing limbs of the mouse
  Nature, 1989
• Spatial and temporal pattern of expression of the cellular retinoic acid-binding protein and the cellular retinol-binding protein during mouse embryogenesis.
  Proceedings of the National Academy of Sciences, 1989
• Molecular cloning and analysis of functional cDNA and genomic clones encoding bovine cellular retinoic acid-binding protein.
  Proceedings of the National Academy of Sciences, 1987
• Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells.
  The Journal of cell biology, 1982
• Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP
  Cell, 1980
• Isolation and identification of 4-hydroxy- and 4-oxoretinoic acid. In vitro metabolites of all-trans-retinoic acid in hamster trachea and liver
  Biochemistry, 1979
• Morphogenesis of malformations in hamsters caused by retinoic acid: Relation to dose and stage at treatment
  Teratology, 1972